Literature DB >> 27528116

The accuracy of extracted target motion trajectories in four-dimensional cone-beam computed tomography for lung cancer patients.

Hiraku Iramina1, Mitsuhiro Nakamura2, Yusuke Iizuka3, Takamasa Mitsuyoshi3, Yukinori Matsuo3, Takashi Mizowaki3, Masahiro Hiraoka3, Ikuo Kanno4.   

Abstract

PURPOSE: To quantify the accuracy of extracted target motion trajectories in dual-source four-dimensional cone-beam computed tomography (4D-CBCT) by comparison with the actual three-dimensional (3D) target motion acquired simultaneously during 4D-CBCT scan.
MATERIALS AND METHODS: 4D-CBCT scans were performed for 19 different sinusoidal-like patterns and 13 lung cancer patients with implanted markers. Internal (In) or external (Ex) surrogates with amplitude (Amp)- or phase (Ph)-based sorting were used for the reconstructions. The targets were a pseudo-tumor and implanted marker for the phantom and clinical studies, respectively. The accuracy was evaluated by determining the maximum error (MaxEi) between the 3D target position extracted from 4D-CBCT and the actual 3D target position detected by fluoroscopy in each ith phase (0⩽i⩽7).
RESULTS: Median peak-to-peak target displacements in the superior-inferior (SI) direction were 20.6 and 20.6mm in the phantom and clinical studies, respectively. In the phantom and clinical studies, the maximum of median MaxEis in the SI direction was 4.6 and 9.2mm in the In_Ph reconstruction. In the clinical study, the maximum of median MaxEis was observed during the end-inhalation phase among all reconstruction approaches.
CONCLUSIONS: This study showed the magnitude of underestimation toward the inferior direction of target motion in clinical 4D-CBCT.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  4D-CBCT; Respiratory signal; Sorting method; Target motion trajectory

Mesh:

Year:  2016        PMID: 27528116     DOI: 10.1016/j.radonc.2016.07.022

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  6 in total

1.  A Bayesian approach for three-dimensional markerless tumor tracking using kV imaging during lung radiotherapy.

Authors:  Chun-Chien Shieh; Vincent Caillet; Michelle Dunbar; Paul J Keall; Jeremy T Booth; Nicholas Hardcastle; Carol Haddad; Thomas Eade; Ilana Feain
Journal:  Phys Med Biol       Date:  2017-03-21       Impact factor: 3.609

2.  Robust optimization of VMAT for lung cancer: Dosimetric implications of motion compensation techniques.

Authors:  Ben R Archibald-Heeren; Mikel V Byrne; Yunfei Hu; Meng Cai; Yang Wang
Journal:  J Appl Clin Med Phys       Date:  2017-08-08       Impact factor: 2.102

3.  Optimization of training periods for the estimation model of three-dimensional target positions using an external respiratory surrogate.

Authors:  Hiraku Iramina; Mitsuhiro Nakamura; Yusuke Iizuka; Takamasa Mitsuyoshi; Yukinori Matsuo; Takashi Mizowaki; Ikuo Kanno
Journal:  Radiat Oncol       Date:  2018-04-19       Impact factor: 3.481

4.  Estimation of effective imaging dose and excess absolute risk of secondary cancer incidence for four-dimensional cone-beam computed tomography acquisition.

Authors:  Yuki Yuasa; Takehiro Shiinoki; Ryota Onizuka; Koya Fujimoto
Journal:  J Appl Clin Med Phys       Date:  2019-10-08       Impact factor: 2.102

5.  Comparative Evaluation of 4-Dimensional Computed Tomography and 4-Dimensional Magnetic Resonance Imaging to Delineate the Target of Primary Liver Cancer.

Authors:  Yukai Chen; Guanzhong Gong; Yinxing Wang; Chenlu Liu; Ya Su; Lizhen Wang; Bo Yang; Yong Yin
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

6.  Quantification of the kV X-ray imaging dose during real-time tumor tracking and from three- and four-dimensional cone-beam computed tomography in lung cancer patients using a Monte Carlo simulation.

Authors:  Mitsuhiro Nakamura; Yoshitomo Ishihara; Yukinori Matsuo; Yusuke Iizuka; Nami Ueki; Hiraku Iramina; Hideaki Hirashima; Takashi Mizowaki
Journal:  J Radiat Res       Date:  2018-03-01       Impact factor: 2.724

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.